Home > North Jersey services > North Jersey legal services

Posted: Sunday, March 18, 2018 7:49 PM


Should you be thinking About Filing A Xarelto Lawsuit?
First Trial Won by the Plaintiffs Resulted in a $28M Xarelto Lawsuit Settlement*
On December 5, 2017, a Philadelphia jury ordered Bayer AG and Johnson & Johnson to pay $26 million in punitive and $1.8 million in compensatory damages to an Indiana couple over inadequate warnings about risks of internal bleeding from Xarelto.
Xarelto is a drug used to thin the blood clots and is prescribed to persons suffering from heart rhythm disorder. Xarelto was beneficial but has shown to be harmful and dangerous to those who consumed it. Harmful side effects were experienced such as excessive bleeding, hemorrhaging, or death. Due to the defective nature of the medication there are currently more than 18,000 cases pending against the manufacturer of Xarelto. Johnson & Johnson, the drug’s makers and marketers will now have to face these lawsuits.
If one of your loved ones or a someone you know has taken Xarelto and have experienced excessive bleeding, hemorrhaging, or death give us a call today to see how we can help. While individual cases vary, the sheer number of patients who have taken action to seek damages after these experiences is overwhelming.

If it is determined that you or a loved one may be eligible for financial compensation, it is your decision whether to hire our law firm. All lawsuits are handled by our Xarelto attorneys under a contingency fee agreement, which means that there are never any fees or expenses paid unless we are successful obtaining a settlement or other recovery in your case.
*These results are not indicative of what you may receive as every case is different, furthermore this firm was the law not the firm handling these cases.

19 North County Line Road, 08527    google map | yahoo map

• Location: Free Consultations, North Jersey

• Post ID: 53532167 northjersey is an interactive computer service that enables access by multiple users and should not be treated as the publisher or speaker of any information provided by another information content provider. © 2018